Published in

American Society of Hematology, Blood, 17(125), p. 2669-2677

DOI: 10.1182/blood-2014-06-584193

Links

Tools

Export citation

Search in Google Scholar

miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Key Points miR-18b overexpression identified patients with poor prognosis in 2 large prospective homogenously treated MCL cohorts. miR-18b overexpression adds prognostic information to the MIPI-B prognosticator.